(TRAMADOL CAPSULES BP 50/100mg)
Tramadol Hydrochloride BP 50/100mg.
Capsule shell contains approved colour.
It is centrally acting synthetic analgesics compound that is neither derived from natural sources nor it is chemically related opiates.
Mechanism of action
It acts via Opiod receptors in CNS to produce analgesia. It has no abuse potential.
Onset of action
30 – 60 mins.
Duration of action
8 – 12 hours.
Nausea, vomiting and dizziness.
Along with Hypnotics, Alcohol and Psychotropic intoxication, Hypersensitivity.
With alcohol, not to drive and operate machinery.
In Pregnancy and Lactation
Safety not established.
A significant increase in Tramadol metabolism. Hypnotics, Tranquilizers and other CNS depressants: Sedative effects are potentiated.
Fatal interaction occurs. Opiod analgesics like Buprenorphine, Butophanol and Pentazocine: May precipitate withdrawal symptoms.
Analgesia is potentiated.
Moderate to severe acute or chronic pain and in painful diagnostic measures and surgery. Arthralgia, musculoskeletal pain, colics, low back pain, pain associated with fractures, dislocation, confusion and osteoarthritis.
Oral: 50 to 100mg 2 to 3 times daily.
Do not exceed 400mg total daily dose.
Not recommended for children below 14 years.
Store below 30oC. Protect from light.
Keep all medicine out of reach of children.
Available in blister of 10 capsules in mono carton and 100 blisters of 10 capsules in one carton.
Osytramadol 50mg: Nafdac No. B4-0639.
Osytramadol 100mg: Nafdac No. B4-0640.
Ossy Adamu Pharmaceutical Company Limited
No. 1 Umunna Street, Odoakpu Onitsha,
Manufactured in India by
Maxheal Laboratories Pvt. Ltd.
H.O. 401 Maxheal House, Bangur Nagar, Goregaon (W.)
Mumbai – 400 090
Factory: 2-7/80-85, Sursez Sachin, Dist. Surat,
Gujarat – 394230